BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19427441)

  • 1. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis.
    Austin BA; Duffy B; Tan C; Rodriguez ER; Starling RC; Desai MY
    Am J Cardiol; 2009 May; 103(10):1429-33. PubMed ID: 19427441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
    Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis.
    Kristen AV; Perz JB; Schonland SO; Hansen A; Hegenbart U; Sack FU; Goldschmidt H; Katus HA; Dengler TJ
    J Heart Lung Transplant; 2007 Dec; 26(12):1313-9. PubMed ID: 18096484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of factors affecting the prognosis of patients with cardiac amyloidosis].
    Zhang Y; Ren YH; Qian G; Zhou CF; Zhang QK; Zhao PC; Liu GS
    Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):305-8. PubMed ID: 23925357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
    Koyama J; Falk RH
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):333-42. PubMed ID: 20394893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis.
    Tei C; Dujardin KS; Hodge DO; Kyle RA; Tajik AJ; Seward JB
    J Am Coll Cardiol; 1996 Sep; 28(3):658-64. PubMed ID: 8772753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis.
    Mohty D; Pibarot P; Dumesnil JG; Darodes N; Lavergne D; Echahidi N; Virot P; Bordessoule D; Jaccard A
    Arch Cardiovasc Dis; 2011 Dec; 104(12):611-8. PubMed ID: 22152513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis.
    Roslan A; Kamsani SH; Nay TW; Tan KL; Hakim N; Tan AM; Megat Samsudim WN; Tan KL; Jauhari AT; Krishnan M; Leong D; Supramaniam T; Tan LK; Nuruddin AA
    Med J Malaysia; 2018 Dec; 73(6):388-392. PubMed ID: 30647209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericardial Effusion and Multiple Organ Involvement Are Independent Predictors of Mortality in Patients with Systemic Light Chain Amyloidosis.
    Yuda S; Hayashi T; Yasui K; Muranaka A; Ohnishi H; Hashimoto A; Ishida T; Tsuchihashi K; Shinomura Y; Watanabe N; Miura T
    Intern Med; 2015; 54(15):1833-40. PubMed ID: 26234222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis.
    Zhao L; Li J; Tian Z; Fang Q
    J Cardiol; 2016 Nov; 68(5):426-430. PubMed ID: 26685729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
    Buss SJ; Emami M; Mereles D; Korosoglou G; Kristen AV; Voss A; Schellberg D; Zugck C; Galuschky C; Giannitsis E; Hegenbart U; Ho AD; Katus HA; Schonland SO; Hardt SE
    J Am Coll Cardiol; 2012 Sep; 60(12):1067-76. PubMed ID: 22883634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term survival in patients with cardiac amyloidosis. Prevalence and characterisation during follow-up.
    Finocchiaro G; Merlo M; Pinamonti B; Barbati G; Santarossa E; Doimo S; Bussani R; Sinagra G
    Heart Lung Circ; 2013 Aug; 22(8):647-54. PubMed ID: 23485473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
    Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
    J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis.
    Tendler A; Helmke S; Teruya S; Alvarez J; Maurer MS
    Amyloid; 2015 Mar; 22(1):61-6. PubMed ID: 25510353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of long-axis function on cardiac surgical outcomes in patients with radiation-associated heart disease.
    Chirakarnjanakorn S; Popović ZB; Wu W; Masri A; Smedira NG; Lytle BW; Griffin BP; Desai MY
    J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1643-51.e1-2. PubMed ID: 25749139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction.
    Giannuzzi P; Temporelli PL; Bosimini E; Silva P; Imparato A; Corrà U; Galli M; Giordano A
    J Am Coll Cardiol; 1996 Aug; 28(2):383-90. PubMed ID: 8800114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.